Is ivermectin safe and appropriate for treating scabies in patients with chronic kidney disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ivermectin for Scabies in CKD: Safe and No Dose Adjustment Required

Yes, ivermectin is safe and appropriate for treating scabies in patients with chronic kidney disease, and importantly, no dose adjustment is required for renal impairment 1.

Key Evidence from Guidelines

The CDC STD Treatment Guidelines explicitly state that "adjustments to ivermectin dosing are not required in patients with renal impairment" 1. This is critical guidance that directly addresses your question and comes from the highest-quality guideline source available.

Recommended Dosing for CKD Patients

For scabies treatment in CKD patients, use:

  • Ivermectin 200 mcg/kg orally, repeated in 2 weeks 1
  • Take with food to increase bioavailability and enhance drug penetration into the epidermis 1
  • No modification needed regardless of CKD stage

Why Ivermectin is Particularly Suitable for CKD

Pharmacokinetic advantages:

  • Ivermectin is metabolized primarily in the liver via CYP3A4 2
  • Less than 1% is excreted unchanged in urine 2
  • Excretion occurs almost exclusively through feces over approximately 12 days 2
  • This hepatic metabolism and fecal elimination pathway makes renal impairment irrelevant to drug clearance

Important Caveats

Avoid ivermectin in severe liver disease: While safe in CKD, the safety of multiple doses in patients with severe hepatic impairment is unknown 1. If your CKD patient has concurrent advanced liver disease, consider topical permethrin 5% cream instead.

Special populations to avoid:

  • Children weighing <15 kg 1, 2
  • Pregnant women (use permethrin instead) 1

Alternative if Ivermectin Contraindicated

If ivermectin cannot be used, permethrin 5% cream is the preferred alternative 1:

  • Applied to all body areas from neck down
  • Washed off after 8-14 hours
  • Effective, safe, and less expensive than ivermectin 1
  • No renal concerns with topical application

Clinical Pearls for CKD Patients

Two doses are essential: Recent evidence shows single-dose regimens have only 58% success rates versus 98% with two doses one week apart 3. The second dose is critical because ivermectin has limited ovicidal activity 1.

Monitor for treatment failure: Pruritus may persist up to 2 weeks post-treatment even with successful therapy 1. Perform at least three stool examinations over three months if treating concurrent strongyloidiasis, as recrudescence can occur 2.

Immunosuppressed CKD patients: If your patient is a transplant recipient or otherwise immunocompromised, be vigilant for crusted scabies, which requires more aggressive treatment and has been associated with secondary infections and mortality 4. These patients may need multiple treatment courses 2.

Bottom Line Algorithm

  1. Confirm scabies diagnosis (burrows, nocturnal pruritus, dermoscopy)
  2. Check for contraindications: severe liver disease, weight <15 kg, pregnancy
  3. If CKD alone: Prescribe ivermectin 200 mcg/kg PO with food, repeat in 2 weeks—no dose adjustment needed
  4. If contraindications present: Use permethrin 5% cream topically
  5. Follow-up at 2 weeks: Persistent symptoms beyond this warrant retreatment consideration

The evidence is clear and consistent: renal function does not impact ivermectin dosing for scabies treatment.

References

Guideline

sexually transmitted diseases treatment guidelines, 2015.

MMWR Recommendations and Reports, 2015

Research

Oral ivermectin to treat scabies: a comparison of two different regimens.

Clinical and experimental dermatology, 2023

Research

Crusted scabies in a renal transplant recipient treated with daily ivermectin: A case report and literature review.

Transplant infectious disease : an official journal of the Transplantation Society, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.